Please login to the form below

Not currently logged in
Email:
Password:

HTA

This page shows the latest HTA news and features for those working in and with pharma, biotech and healthcare.

UK, Germany back routine use of J&J’s Tremfya

UK, Germany back routine use of J&J’s Tremfya

The swift decision by two of Europe’s key HTA bodies reflects the positive results demonstrated in clinical studies of guselkumab for the treatment of moderate to severe plaque psoriasis, ”said

Latest news

  • Daily Brief: Trump's America First speech, Is Europe's PRIME speeding up drug approvals?

    What marks PRIME out from the FDA’s Breakthrough Therapy Designation is that it also includes input on market access issues, by allowing early conversations with health technology assessment (HTA) bodies ... Market access issues remain a major headache

  • 2018 by Darwin 2018 by Darwin

    As failed launches slow uptake and HTA rejections show us, a business model that has most of the costs of innovation but delivers few of its benefits is usually selected against

  • Transforming access in rare diseases Transforming access in rare diseases

    Project HERCULES is a unique initiative set to radically improve the way evidence is generated for HTA submissions. ... history of the disease and developing a new quality of life metric, which is essential in cost-utility based HTA processes.

  • Duchenne UK and pharma partner pilot data-sharing HTA approach Duchenne UK and pharma partner pilot data-sharing HTA approach

    Duchenne UK and pharma partner pilot data-sharing HTA approach. Pfizer, Roche and PTC Therapeutics are among those participating in Project Hercules. ... HTA agencies can struggle with decisions in the absence of a solid evidence base, be that data on

  • EMA forges closer ties with HTA umbrella group EMA forges closer ties with HTA umbrella group

    EMA forges closer ties with HTA umbrella group. Agrees joint work plan with the European Network for Health Technology Assessment. ... introduced tool to try to standardise the assessment process for new medicinal products and avoid duplicating work by

More from news
Approximately 35 fully matching, plus 152 partially matching documents found.

Latest Intelligence

  • The valuable brand The valuable brand

    If you need evidence of this, consider how few launches achieve their goals, the frequent rejection of new products by HTAs or the increasing price pressure faced by even successful brands.

  • Drug pricing

    Healthcare terms - Drug pricing.

  • Medical education

    Healthcare terms - Medical education.

  • Market access

    Healthcare terms - Market access.

  • The gold standard of scientific evidence The gold standard of scientific evidence

    Because of the perceived quality of clinical trials data, RCT data is used in most health technology assessment (HTA) appraisals around the world; in 2015, 90% of CADTH appraisals, 80% of

More from intelligence
Approximately 14 fully matching, plus 49 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 4 fully matching, plus 17 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Makara Health

Independent healthcare communications agency with a passion to develop inspirational ideas that create sustained and positive change. Whether it is...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics